Table 2 Results of antibiotic susceptibility tests of Acinetobacter sp. DW-1.

From: Acinetobacter sp. DW-1 immobilized on polyhedron hollow polypropylene balls and analysis of transcriptome and proteome of the bacterium during phenol biodegradation process

Antimicrobial agents

Breakpoints (mm)

Tolerance (Breakpoints (mm))

Susceptible (S)

Intermediate (I)

Resistant (R)

 

Kanamycin(K)

≥18

14–17

≤13

S(26.96)

Streptomycin(S)

≥15

11–14

≤10

S(16.09)

Tetracycline(TE)

≥19

15–18

≤14

S(20.02)

Ampicillin(AMP)

≥17

14–16

≤13

S(14.72)

Chloramphenicol(C)

≥26

20–25

≤19

R(15.84)

Ciprofloxacin(CIP)

≥21

16–20

≤15

S(25.69)

Meropenem(MEM)

≥16

14–15

≤13

S(29.55)

Cephalothin(KF)

≥18

15–17

≤14

S(21.52)

Tobramycin(TOB)

≥15

13–14

≤12

S(21.61)

Gentamicin(CN)

≥15

13–14

≤12

S(20.21)

Ceftazidime(CAZ)

≥21

18–20

≤17

I(18.86)

Cefotaxime(CTX)

≥23

15–22

≤14

I(17.67)

Imipenem(IPM)

≥16

14–15

≤13

S(28.67)

Cefepime(FEP)

≥18

15–17

≤14

S(19.45)

Trimethoprim-Sulfamethoxazoie(SXT)

≥16

11–15

≤10

S(19.07)

Levofloxacin(LEV)

≥17

14–16

≤13

S(29.38)

Aztreonam (ATM)

≥21

18–20

≤17

R(0)

Back to article page